CTOs on the Move

Equipment Placement Svc

www.equipmentplacement.com

 
Equipment Placement Svc is a Streetman, TX-based company in the Healthcare, Pharmaceuticals, and Biotech sector.
  • Number of Employees: 25-100
  • Annual Revenue: $1-10 Million

Executives

Name Title Contact Details

Similar Companies

Life-Tech

Life-Tech is a Stafford, TX-based company in the Healthcare, Pharmaceuticals, and Biotech sector.

Picwell

Picwell is a Philadelphia-based, healthcare technology company providing leading enterprise solutions to enhance healthcare benefits and improve the consumer experience. Picwell`s flagship offering is a SaaS-based decision support product that uses artificial intelligence to match individuals to the right health benefits during enrollment by predicting future care considerations, estimating out-of-pocket expenses, and accounting for individual preferences. Other solutions support consumerism and high-deductible health plan adoption, consumer engagement, and risk management. We are on a mission to transform choice in healthcare. More than 200 million people choose benefits each year, but the complexity of the healthcare system makes it challenging to get the right protection based on individual care and cost needs. We imagine a future where healthcare benefits are simple – and people can make the right choice with confidence.

Vitrolife AB

Vitrolife AB is one of the leading providers in Healthcare, Pharmaceuticals, and Biotech. It is based in Englewood, CO. To find more information about Vitrolife AB, please visit www.vitrolife.com

Core Health & Fitness

Core Health & Fitness is more than gym equipment, we offer innovative solutions for all your facility needs. This is why we’ve brought together five of the most recognizable fitness brands to ensure our customers can offer their members authentic fitne...

Acucela

Acucela is a clinical-stage biotechnology company that specializes in discovering and developing novel therapeutics to treat and slow the progression of sight-threatening ophthalmic diseases impacting millions of individuals worldwide. Acucela currently has the following candidates in development with Otsuka Pharmaceutical: emixustat hydrochloride for GA associated with dry AMD based on Acucela’s proprietary visual cycle modulation; and OPA-6566 for ocular hypertension and glaucoma.